V Pezzino
Overview
Explore the profile of V Pezzino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baroni M, Giorgino F, Pezzino V, Scaroni C, Avogaro A
Nutr Metab Cardiovasc Dis
. 2016 Feb;
26(2):85-102.
PMID: 26905474
Background: Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. Aims: The purpose of these guidelines is to assist clinicians and other health...
2.
Baroni M, Giorgino F, Pezzino V, Scaroni C, Avogaro A
J Endocrinol Invest
. 2016 Jan;
39(2):235-55.
PMID: 26718207
Hyperglycemia is a common feature associated with states of increased growth hormone secretion and glucocorticoid levels. The purpose of these guidelines is to assist clinicians and other health care providers...
3.
Regalbuto C, Malandrino P, Frasca F, Pellegriti G, Le Moli R, Vigneri R, et al.
J Endocrinol Invest
. 2012 Jul;
36(4):249-54.
PMID: 22776915
Background: The tall cell variant (TCV) is a relatively rare variant of papillary thyroid cancer. Since a controversy exists whether or not the TCV has a worse outcome, the aim...
4.
Beck E, Sciacca L, Pandini G, Jaeger W, Pezzino V
Methods Mol Med
. 2011 Feb;
39:485-92.
PMID: 21340804
The IGF-1 receptor (IGF-1-R) belongs to the tyrosine kinase growth factor receptor family. It is structurally similar to, but distinct from, the insulin receptor, with which it shares a 70%...
5.
Regalbuto C, Tumminia A, Malandrino P, Salamone S, Pezzino V
J Endocrinol Invest
. 2010 Jul;
33(6):434-5.
PMID: 20631495
No abstract available.
6.
Regalbuto C, Scollo G, Pandini G, Ferrigno R, Pezzino V
J Endocrinol Invest
. 2009 Dec;
33(5):300-5.
PMID: 19955847
In developed countries, the use of iodised salt represents the best prophylaxis of endemic goitre in areas exposed to iodine deficiency. In the present study we re-evaluated goitre prevalence and...
7.
Pezzino V, Sipione C, Tita P, Vigneri R
J Endocrinol Invest
. 2009 Jul;
33(1):71.
PMID: 19625760
No abstract available.
8.
Regalbuto C, Marturano I, Condorelli A, Latina A, Pezzino V
J Endocrinol Invest
. 2009 May;
32(2):134-8.
PMID: 19411811
Oral administration of radioactive iodine (131I) is a well-known and effective procedure for the treatment of hyperthyroidism. However, the optimal dose is still a matter of debate, as is the...
9.
Pezzino V, Sipione C, Vigneri R
J Endocrinol Invest
. 2008 Dec;
31(10):939.
PMID: 19092302
No abstract available.
10.
Papa G, Fedele V, Chiavetta A, Lorenti I, Leotta C, LUCA S, et al.
Acta Diabetol
. 2008 Jan;
45(1):53-9.
PMID: 18180864
Glycemic control in elderly persons with type 2 diabetes mellitus (T2DM) is challenging because they are more likely to have other age-associated medical conditions and to experience hypoglycemia during intensive...